.png)
Pharmacist Clinical Coordinator – Hematology/Oncology
Levine Cancer Institute, Atrium Health
Concord, North Carolina, United States
Donald C Moore, PharmD, BCPS, BCOP, DPLA is a Pharmacist Clinical Coordinator in Hematology/Oncology at Levine Cancer Institute.
He received his Doctor of Pharmacy from the Massachusetts College of Pharmacy in Boston, Massachusetts. He completed a PGY-1 pharmacy practice residency at Steward St. Elizabeth's Medical Center in Boston, Massachusetts. His practice area is inpatient and outpatient hematology/oncology; he subspecializes in multiple myeloma, lymphoma, and non-malignant hematology. At Levine Cancer Institute, Dr. Moore provides care to many patients with multiple myeloma; treating patients on both clinical trials and standard of care agents, he has extensive first-hand experience with the newest agents available for multiple myeloma. Dr. Moore has authored numerous original research articles, review articles, and case reports in the area of multiple myeloma in journals such as Clinical Lymphoma Myeloma & Leukemia, Annals of Hematology, Leukemia & Lymphoma, and Journal of Oncology Pharmacy Practice. He has also served as an expert reviewer for numerous board certification activities pertaining to multiple myeloma, including the ASHP/ACCP BCOP Review and Recertification Course's multiple myeloma chapter and the ACCP 2020 Pharmacotherapy Self-Assessment Program (PSAP) chapter on multiple myeloma. Dr. Moore has also been awarded the 2020 "40 Under 40 in Cancer" Award by the National Community Oncology Dispensing Association, The Lynx Group, and the Association of Value-Based Cancer Care.